Home > Cashflow Statement > SOTAC PHARMACEUTICALS

SOTAC PHARMACEUTICALS
Cash Flow from Financing Activities

    Back to Cashflow Statement
COMMUNITY POLL
for SOTAC PHARMACEUTICALS
Please provide your vote to see the results

SOTAC PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Cash Flow from Financing Activities ₹30 Cr₹13 Cr₹-2.83 Cr₹3.38 Cr₹11 Cr

What is the latest Cash Flow from Financing Activities ratio of SOTAC PHARMACEUTICALS ?

The latest Cash Flow from Financing Activities ratio of SOTAC PHARMACEUTICALS is ₹30 Cr based on Mar2024 Consolidated results.
Year Cash Flow from Financing Activities
Mar2024₹30 Cr
Mar2023₹13 Cr
Mar2022₹-2.83 Cr
Mar2021₹3.38 Cr
Mar2020₹11 Cr

How is Cash Flow from Financing Activities of SOTAC PHARMACEUTICALS Trending?

Years Cash Flow from Financing Activities % Change
Mar2024 ₹30 Cr
124.86
Mar2023 ₹13 Cr
Positive
Mar2022 ₹-2.83 Cr
Negative
Mar2021 ₹3.38 Cr
-70.36
Mar2020 ₹11 Cr -

Compare Cash Flow from Financing Activities of peers of SOTAC PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS ₹119.9 Cr -2.7% -13.9% -19.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,936.0 Cr -5.8% -3.2% 35.1% Stock Analytics
DIVIS LABORATORIES ₹152,157.0 Cr -2.8% -3.6% 44.7% Stock Analytics
CIPLA ₹116,200.0 Cr -3.9% -0.5% 13.9% Stock Analytics
DR REDDYS LABORATORIES ₹111,325.0 Cr -1.2% 7.1% 17.8% Stock Analytics
ZYDUS LIFESCIENCES ₹98,037.4 Cr -2.7% -0.1% 40.9% Stock Analytics


SOTAC PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS

-2.7%

-13.9%

-19.6%

SENSEX

-2.1%

-6.4%

7%


You may also like the below Video Courses